-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
January 01, 2022 - Reporting on adverse events was sparse. … , nausea, sedation) and withdrawals
from studies due to adverse events. … , nausea, sedation) and
study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … scale; WAE = withdrawal due to due
adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e5.xlsx
March 13, 2023 - Events Other Reported Outcomes Funding Source Risk of Bias
21087411 Bestard, 2011 Prospective cohort … C
% (n/N)
Any adverse event
3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07)
Serious adverse events: none in any group
Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04)
Withdrawals due to adverse … events: 4.65% (10/215) vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias
21087411 Bestard, 2011 Prospective cohort … C
% (n/N)
Any adverse event
3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07)
Serious adverse events: none in any group
Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04)
Withdrawals due to adverse … events: 4.65% (10/215) vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
January 01, 2022 - Events Other Reported Outcomes Funding Source Risk of Bias
21087411 Bestard, 2011 Prospective cohort … C
% (n/N)
Any adverse event
3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07)
Serious adverse events: none in any group
Withdrawals due to adverse events … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04)
Withdrawals due to adverse … events: 4.65% (10/215) vs.
-
effectivehealthcare.ahrq.gov/products/nonopioid-chronic-pain/protocol
March 01, 2019 - adverse events (including falls, fractures, motor vehicle accidents), and specific adverse events, according … events, and serious adverse events. … Specific adverse events for each drug class, such as gastrointestinal events, cardiovascular events, … events, serious adverse events, overdose (intentional and unintentional), misuse, and dependence. … Key specific adverse events, according to drug class, such as gastrointestinal and cardiovascular events
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
February 01, 2019 - Harms and Adverse Events
a. … adverse events, according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as
gastrointestinal events, cardiovascular events, … events, serious adverse events,
overdose (intentional and unintentional),
misuse, and dependence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/inguinal-hernia_research-protocol.pdf
August 15, 2011 - no
mesh
Outcomes Patient-oriented effectiveness outcomes and adverse events (see list of outcomes … Adverse events include any unintended effects such as chronic pain, infection, small bowel perforation … The following will always be considered
objective outcomes: adverse events, hospital
stay, office … This item will only be used for the following
outcomes: hernia recurrence, adverse events,
QOL, FCT … MCSDs for different
adverse events
If meta-analysis is deemed appropriate and possible for a given
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
September 01, 2016 - events by organ system.
2. … • Adverse event and deaths. … ClinicalTrials.gov began to mandate reporting of adverse
events in September 2009 as serious adverse … events and non-serious adverse events. … We
will compare the total adverse events reported in ClinicalTrials.gov compared with the
total reported
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
December 29, 2015 - When lesinurad was combined with xanthine oxidase inhibitors,
commonly reported adverse events were … However, the experts warned that lesinurad uptake could be
limited by concern about adverse events, … adverse events, than patients given placebo. … Occurrence of adverse events, including serious events, was similar in patients
given baricitinib or … Adverse events/nonfatal serious adverse events rates were
78.1%/8.6% and 82.4%/12.9% in patients who
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
April 01, 2022 - events and withdrawals due to adverse
events for each included study. … ; VAS = visual analog scale; WAE = withdrawal due to due adverse events. … Events and
Withdrawals Due to Adverse
Events
Bestard, 2011
Moderate
Prospective cohort
Neuropathic … Events and
Withdrawals Due to Adverse
Events
Lee, 2021b
Moderate
Matched cohort
NR
A: Chronic … scale; WAE = withdrawal due to due adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
December 01, 2014 - When lesinurad
was combined with xanthine oxidase inhibitors, commonly reported adverse events were … However, they
warned, lesinurad uptake could be limited by adverse events, such as kidney complications … back pain,
nasopharyngitis, and upper respiratory tract infection.6 The most common adverse events … The experts warned that lesinurad uptake could be
limited by adverse events such as kidney complications … events, which could require additional adverse event monitoring
while patients are taking lesinurad
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-2-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - adverse events according to drug class? … Harms and Adverse Events
a. … adverse events according to drug class? … events, and serious adverse events. … Specific adverse events for each drug class, such as
gastrointestinal events, cardiovascular events,
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
March 01, 2022 - Reporting on adverse events
was sparse. … , nausea, sedation) and withdrawals
from studies due to adverse events. … , nausea, sedation) and
study withdrawal due to adverse events. … events, and withdrawals due to adverse events for each included study. … scale; WAE = withdrawal due to due
adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - No
serious adverse events were
observed. … There were no treatment-
related adverse events. … and withdrawals due to adverse events compared with placebo. … No serious adverse events
were observed. … No treatment related adverse events were
reported.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
April 01, 2012 - to adverse events)? … events, withdrawal due to adverse events, renal
dysfunction, hepatotoxicity, QT interval, and bleeding … No withdrawals due to adverse events or other
adverse events were observed.59
Garlic
Four small short-term … events, bleeding, renal dysfunction,
hepatotoxicity, and serious adverse events). … events,42,73 renal dysfunction,42,73 serious adverse events,42
diarrhea,73 vomiting,73 nausea,73 adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
October 01, 2010 - of the various adverse events were not always
comparable." … Limitations of evaluation of adverse events have been added to
Discussion section. … Discussion Adverse effects: “There is a moderate level of evidence to show that
adverse events associated … These long-term
adverse events need to be explored in future studies. … types of adverse events were
different between groups, as would be expected.
-
effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
February 26, 2013 - FFR confers a lower risk of the composite endpoint of death or myocardial infarction (MI) or of major adverse … cardiac events; and (c) FFR leads to fewer stents implanted and reduces the cost of the procedure. … cardiac events or its individual components. … intermediate coronary lesion confers a lower risk of composite endpoint of death or MI, or of major adverse … cardiac events; leads to fewer stents being implanted; and reduces procedural costs.
-
effectivehealthcare.ahrq.gov/products/tympanostomy-tubes/research-2017
May 05, 2017 - Benefits of TT placement must be weighed against a variety of adverse events. … with chronic otitis media with effusion and recurrent acute otitis media, summarize the frequency of adverse … The benefits of TT placement must be weighed against a variety of adverse events.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
March 27, 2014 - In children with JIA, does the rate and type of adverse eventsf differ
between the various DMARDs or … How do the efficacy, effectiveness, safety, and adverse effects of
treatment with DMARDs differ among … with DMARDs, we focused primarily on serious infections and the development of cancer when assessing adverse … events. … Other adverse events considered included mortality, hepatitis, bone marrow suppression, nausea or vomiting
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_executive.pdf
June 01, 2013 - had no adverse events data. … Thus, strength of evidence for long-term adverse
events is rated insufficient. … Data reported on adverse events also have several
limitations. … event category; thus, the rate estimate for most
adverse events is imprecise. … As such, the rates of adverse
events may be biased and lower than actual.